sentiment_stocks Tuesday, 06/11/19 09:16:15 PM Re: exwannabe post# 232754 Post # of 236932 I frankly don't understand your problem then. If they revise the SAP for an outdated criteria that doesn't work for an immunotherapy, then why do you have a problem with that? Shouldn't you instead be happy or pleased that they will be able to assess PFS under a fair set of criteria? And if DCVax doesn't work, then it won't even matter. But if it does, then this helps to give them a fair chance at approval. And that should help patients, and it should help all of us longs who have been horribly underwater and terribly diluted over the past 5 years. I honestly don't understand why wouldn't you be pleased with that outcome? That the treatment have a revised SAP that will more fairly assess the primary endpoint for this trial?